EU Clinical Trial Information System (CTIS)

Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.

I searched for some studies on AstraZeneca Clinical Trials, and found these studies that may also be of interest to you.
Here is the link to my search results

Official Title

The purpose of this study is to study the changes in protein in lung cells of Asian patients with advanced non small cell lung cancer.

To study the changes in protein in lung cells of Asian patients with advanced non-small cell lung cancer (NSCLC)

A molecular epidemiology study in Asian patients with advanced NSCLC of adeno histology to assess EGFR mutation status.

Research Site

A molecular epidemiology study in Asian patients with advanced non-small cell lung cancer (NSCLC) of adeno histology to assess epidermal growth factor receptor (EGFR) mutation status

To study the changes in protein in lung cells of Asian patients with advanced non-small cell lung cancer (NSCLC) - PIONEER

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Exclusion Criteria

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=603&filename=CSR-D7913L00086.pdf

CSR-D7913L00086.pdf

Trial Results Summaries

Contacts

Contact

Investigators

Principal Investigator